What is Pfizer's U.S. — property, plant and equipment, net?

Pfizer (PFE) reported U.S. — property, plant and equipment, net of $9.68B in Q4 2025.

How has Pfizer's U.S. — property, plant and equipment, net changed year-over-year?

Pfizer's U.S. — property, plant and equipment, net decreased by 0.7% year-over-year, from $9.75B to $9.68B.

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Market cap$143.91B+5.9%

Enterprise value$206.58B+5.4%

P/E11.9×—

P/S2.3×+0.1×

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Pfizer's U.S. — property, plant and equipment, net?: Pfizer (PFE) reported U.S. — property, plant and equipment, net of $9.68B in Q4 2025.
How has Pfizer's U.S. — property, plant and equipment, net changed year-over-year?: Pfizer's U.S. — property, plant and equipment, net decreased by 0.7% year-over-year, from $9.75B to $9.68B.